Acanthamoeba keratitis - A review.
Raghavan A, Rammohan R.
Indian J Ophthalmol. 2024 Apr 1;72(4):473-482. doi: 10.4103/IJO.IJO_2627_23. Epub 2024 Mar 8.
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.
Lorenzo-Morales J, Khan NA, Walochnik J.
Parasite. 2015;22:10. doi: 10.1051/parasite/2015010. Epub 2015 Feb 18.
Acanthamoeba keratitis.
Graffi S, Peretz A, Jabaly H, Naftali M.
Isr Med Assoc J. 2013 Apr;15(4):182-5.
Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach.
Kaufman AR, Tu EY.
Ocul Surf. 2022 Jul;25:26-36. doi: 10.1016/j.jtos.2022.04.003. Epub 2022 Apr 22.
Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology.
de Lacerda AG, Lira M.
Ophthalmic Physiol Opt. 2021 Jan;41(1):116-135. doi: 10.1111/opo.12752. Epub 2020 Oct 29.
Acanthamoeba keratitis.
Ishibashi Y.
Ophthalmologica. 1997;211 Suppl 1:39-44. doi: 10.1159/000310885.
[Acanthamoeba keratitis].
Bouheraoua N, Labbé A, Chaumeil C, Liang Q, Laroche L, Borderie V.
J Fr Ophtalmol. 2014 Oct;37(8):640-52. doi: 10.1016/j.jfo.2014.05.004. Epub 2014 Aug 29.
Acanthamoeba Keratitis: Current Status and Urgent Research Priorities.
Khan NA, Anwar A, Siddiqui R.
Curr Med Chem. 2019;26(30):5711-5726. doi: 10.2174/0929867325666180510125633.
Acanthamoeba Keratitis.
Fu L, Gomaa A.
N Engl J Med. 2019 Jul 18;381(3):274. doi: 10.1056/NEJMicm1817678.
The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.
Dart JKG, Papa V, Rama P, Knutsson KA, Ahmad S, Hau S, Sanchez S, Franch A, Birattari F, Leon P, Fasolo A, Kominek EM, Jadczyk-Sorek K, Carley F, Hossain P, Minassian DC.
Ophthalmology. 2024 Mar;131(3):277-287. doi: 10.1016/j.ophtha.2023.09.031. Epub 2023 Oct 5.
